LifeTech Scientific Corporation
LFTSF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$858.7M
Close$
$0.16
20.6% downside
Current Fair Value
20.6% downsideOvervalued by 20.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $858.70 Million |
|---|---|
| Enterprise Value | $-80,974,000.00 |
| Earnings per Share | $0.03 |
| Beta | 0.31 |
| Outstanding Shares | 4,293,500,000 |
Return
| Return on Equity | 3.93% |
|---|---|
| Return on Assets | 2.74% |
| Return on Invested Capital | 6.23% |
Valuation & Multiples
| P/E Ratio | 101.62 |
|---|---|
| PEG | -62.59 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.19 |
| Enterprise Value to EBIT | 23.64 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
March 31, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About LifeTech Scientific Corporation
1,245 employees
CEO: Yue Hui Xie
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asi...